Patents Assigned to Dana-Farher Cancer Institute, Inc.
  • Compositions and methods for sensitizing a neoplastic cell to radiation
    Patent number: 9439909
    Abstract: The invention provides for the use of radiation sensitizing agents in combination with radiation for the treatment of neoplasia, methods for the identification of genotype-specific radiation sensitizing agents, and methods of identifying patients who could benefit from therapy with a genotype-specific radiation sensitizing agent.
    Type: Grant
    Filed: August 22, 2014
    Date of Patent: September 13, 2016
    Assignees: The Broad Institute, Inc., Dana-Farher Cancer Institute, Inc., President and Fellows of Harvard College
    Inventors: Mohamed Abazeed, Matthew Meyerson, Drew Adams